Status:
COMPLETED
Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.
Lead Sponsor:
GlaxoSmithKline
Conditions:
Asthma
Eligibility:
All Genders
4-11 years
Phase:
PHASE4
Brief Summary
Comparison of two asthma treatments by lung function measures.
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Currently receiving 200-800mcg/day beclomethasone dipropionate.
- sRAW value of 1.3 kPa's.
- Exclusion Criteria:
- 3 or more courses of oral steroids in last 12 months.
Exclusion
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2005
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT00169546
Start Date
January 1 2003
End Date
December 1 2005
Last Update
September 15 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Wellington, New Zealand, 6004
2
GSK Investigational Site
Manchester, Lancashire, United Kingdom, M23 9LT